OCD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 13 to 17 years who are being seen as outpatients (not admitted to hospital).
- People who have been diagnosed with Obsessive Compulsive Disorder (OCD) that is rated as moderate to severe based on a standard assessment tool called the CY-BOCS II.
- People who have been on the same psychiatric medications and/or therapy for at least 8 weeks before the study, and who are willing to keep those the same throughout the study.
- People who are currently taking medications may continue to do so, with daily usage recorded during the study.
- People who are able to give their own agreement to participate, with a parent or legal guardian also able to give formal consent on their behalf.
- People who are able to tolerate the procedures involved in the clinical study.
- People who complete the screening forms without any factors that would rule out participation.
Who may not be able to join:
- People with a history of schizophrenia, bipolar disorder, substance or alcohol use disorder, a current elevated risk of suicide, or who have previously had brain surgery or electroconvulsive therapy (ECT).
- People with serious neurological conditions, such as severe cognitive impairment, a seizure disorder, or certain structural brain conditions (confirm with trial site for specifics).
- People for whom TMS (the treatment used in this trial) is not considered safe — for example, those with an implanted medical device, metal anywhere in the head (excluding dental implants), certain tic conditions, medications or illnesses that increase seizure risk, or a parent or sibling with a seizure disorder.
- People with an unstable physical or metabolic health condition, such as uncontrolled high blood pressure or malnutrition related to an eating disorder.
- People who are pregnant or breastfeeding (this is assessed by questionnaire and a pregnancy test).
- People who are currently taking, or plan to continue taking, any medication listed on the trial's prohibited medications list (confirm with trial site for the full list).
- People who the lead researcher determines would not be able to complete the full study protocol.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: James T McCracken, MD, University of California, San Francisco
Phone: 415-514-5743
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Completion rate; Adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.